CD36 and metabolic dysfunction-associated steatotic liver disease: Hepatic PRLR gene expression was significantly reduced in patients with NAFLD and negatively correlated with CD36 gene expression, a key transporter of free fatty acid uptake in the liver involved in NAFLD development.